In our study, we determined that URGCP/URG4 overexpression promoted the resistance to cisplatin-induced bladder cancer cells apoptosis, indicating its function and potential utilization in bladder cancer chemotherapeutic treatment. Here, URGCP is linked to urinary bladder cancer.